…
Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services in Germany, the United Kingdom, France, Europe, the United States, Asia, Australia, Africa, and internationally. It operates through Property & Casualty Reinsurance; and Life & Health Reinsurance segments. The company provides property and casualty reinsurance solutions for agricultural, livestock, and bloodstock; aviation and space; natural catastrophe; credit, surety, and political risks; cyber; digital; marine and upstream energy; natural catastrophes; advanced and facultative business, insurance-linked securities and structured reinsurance; and parametric solutions. It also offers risk solutions in the areas of critical illness, disability, health, longevity, long term care, and mortality. In addition, the company offers group life, retirement, lifestyle, credit life, and Takaful reinsurance products. Further, the company provides various financial solutions, including new-business financing; monetization of embedded value; reserve and solvency relief; and reinsurance and solvency II businesses. The company was formerly known as Hannover Rückversicherung AG and changed its name to Hannover Rück SE in March 2013. Hannover Rück SE was founded in 1966 and is based in Hanover, Germany. Hannover Rück SE operates as a subsidiary of Talanx AG.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Hannover Rück SE is a global reinsurance group providing property & casualty and life & health reinsurance across multiple regions. Long-term growth drivers include geographic and product diversification, underwriting scale, and potential support from firmer pricing and higher interest rates that may benefit earnings. Its capital-management track record and broad portfolio appears positioned to support resilience through insurance cycles.
The company faces risks from large natural-catastrophe losses, adverse reserve development, investment-market and interest-rate volatility, and regulatory or rating pressure that could weaken capital and earnings; investors should monitor these exposures.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 3411.52M | 3213.30M | 1854.00M | 1996.37M | 1651.79M |
| Minority interest | -126.00M | -68.10M | -51.51M | -136.00M | -68.89M |
| Net income | 2639.01M | 2328.70M | 1824.80M | 1406.73M | 1231.33M |
| Selling general administrative | - | - | - | 575.76M | 510.71M |
| Gross profit | 22866.20M | 2528.70M | 1040.90M | 31596.27M | 26149.01M |
| Reconciled depreciation | - | - | - | -83.89M | 150.66M |
| Ebit | - | - | 2011.60M | 1948.68M | 1660.32M |
| Ebitda | 3546.40M | 3365.40M | 2102.50M | 1864.79M | 1810.99M |
| Depreciation and amortization | - | - | 90.90M | -83.89M | 150.66M |
| Operating income | 3411.52M | 3213.10M | 1854.00M | 1948.68M | 1660.32M |
| Other operating expenses | 20604.90M | 557.70M | 724.40M | 29794.03M | 24497.22M |
| Interest expense | 133.55M | 152.10M | 157.60M | 113.07M | 98.32M |
| Tax provision | 645.30M | 816.50M | 402.83M | 453.63M | 351.57M |
| Interest income | 540.10M | 640.30M | 550.10M | 1391.33M | 1281.51M |
| Net interest income | -92.20M | -109.10M | -70.15M | -42.85M | -48.28M |
| Income tax expense | 645.06M | 816.50M | 26.40M | 453.63M | 351.57M |
| Total revenue | 24017.80M | 2655.40M | 1129.60M | 31596.27M | 26149.01M |
| Total operating expenses | 19453.30M | -684.40M | -813.10M | 29794.03M | 24965.50M |
| Cost of revenue | 1151.60M | 126.70M | 88.70M | - | - |
| Total other income expense net | -26789.96M | 0.20M | -117.20M | -88.32M | -77.42M |
| Net income from continuing ops | 2767.50M | 2396.80M | 1741.44M | 1542.74M | 1300.22M |
| Net income applicable to common shares | - | - | - | 1406.73M | 1231.33M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 71300.39M | 72127.30M | 65665.10M | 86952.37M | 82902.25M |
| Intangible assets | 118.36M | 131.80M | 134.70M | 158.01M | 164.19M |
| Other current assets | - | -57393.10M | 159.40M | 16173.66M | 14985.24M |
| Total liab | 57375.20M | 59439.00M | 54645.60M | 78204.66M | 70146.02M |
| Total stockholder equity | 12923.86M | 11794.50M | 10126.80M | 8090.97M | 11885.00M |
| Other current liab | -4455.63M | 205.47M | -3048.60M | -2822.16M | -2380.68M |
| Common stock | 120.55M | 120.60M | 120.60M | 120.60M | 120.60M |
| Capital stock | 120.60M | 120.60M | 120.60M | 120.60M | 120.60M |
| Retained earnings | 12695.64M | 10595.10M | 9124.00M | 9699.37M | 8985.77M |
| Other liab | - | - | - | 46846.10M | 43646.13M |
| Good will | 77.87M | 79.90M | 78.00M | 77.36M | 83.93M |
| Other assets | - | 67264.92M | 65665.10M | -12862.92M | -16370.33M |
| Cash | 1051.11M | 1253.10M | 1054.80M | 1323.17M | 1355.11M |
| Total current liabilities | -4274.00M | 809.37M | -1897.90M | 2822.16M | 2380.68M |
| Current deferred revenue | - | - | 225.90M | - | - |
| Net debt | 3089.64M | 3415.80M | 3820.60M | 4187.19M | 3015.14M |
| Short term debt | 181.63M | - | 281.70M | - | - |
| Short long term debt total | 4140.75M | 4668.90M | 4875.40M | 5510.36M | 4370.26M |
| Other stockholder equity | 724.33M | 724.60M | 724.60M | -1728.99M | 2778.64M |
| Property plant equipment | - | - | - | 161.99M | 165.34M |
| Total current assets | 3076.95M | 1714.80M | 54455.50M | 46648.18M | 47587.04M |
| Long term investments | 63667.40M | 63283.00M | 57592.40M | 50895.54M | 50595.75M |
| Net tangible assets | - | - | - | 7879.90M | 11662.58M |
| Short term investments | 57686.10M | 56140.00M | 51579.50M | 45325.01M | 46231.92M |
| Net receivables | 2025.84M | 1714.80M | 1661.80M | 11996.90M | 7404.58M |
| Long term debt | 4050.20M | 4562.30M | 4774.60M | 5398.70M | 4257.70M |
| Accounts payable | - | - | 698.90M | 2822.16M | 2380.68M |
| Accumulated other comprehensive income | -616.67M | 354.20M | 157.60M | - | - |
| Non currrent assets other | 67542.96M | 6265.90M | -47371.20M | -53167.10M | -51685.55M |
| Non current assets total | 68223.44M | 70412.50M | 11209.60M | 53167.10M | 51685.55M |
| Capital lease obligations | 92.10M | 106.60M | 100.80M | 111.67M | 112.55M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | -4328.60M | -4412.10M | -5409.47M | -5382.77M | -5256.27M |
| Change to liabilities | - | - | - | 346.84M | 241.33M |
| Total cashflows from investing activities | -4052.58M | -4412.10M | -4509.80M | -5382.77M | -5261.06M |
| Net borrowings | - | - | - | 856.53M | 865.51M |
| Total cash from financing activities | -1721.75M | -1105.00M | -1501.40M | 133.25M | 277.51M |
| Change to operating activities | - | - | - | 4365.02M | 4465.22M |
| Net income | 2640.51M | 2396.80M | 1824.80M | 1542.74M | 1300.22M |
| Change in cash | -52.97M | 198.30M | -268.40M | -31.94M | 77.04M |
| Begin period cash flow | 1104.08M | 1054.80M | 1323.20M | 1355.11M | 1278.07M |
| End period cash flow | 1051.11M | 1253.10M | 1054.80M | 1323.17M | 1355.11M |
| Total cash from operating activities | 5684.77M | 5681.90M | 5785.50M | 5164.36M | 4940.46M |
| Issuance of capital stock | 0.00M | 16.30M | 27.10M | 0.03M | 0.31M |
| Depreciation | - | - | 90.90M | -83.89M | 150.66M |
| Other cashflows from investing activities | 16.29M | -213.90M | -26.90M | 238.87M | 30.06M |
| Dividends paid | 1121.08M | 913.10M | 723.60M | -723.48M | -588.48M |
| Change to account receivables | - | - | 449.80M | -780.12M | -844.02M |
| Sale purchase of stock | 0.00M | -1.70M | 0.00M | -0.13M | -0.34M |
| Other cashflows from financing activities | -0.10M | -10.20M | -47.60M | 894.82M | 881.61M |
| Change to netincome | - | - | - | -427.41M | -287.19M |
| Capital expenditures | 5684.77M | 0.00M | 0.00M | 572.73M | 344.12M |
| Change in working capital | 2550.24M | 3731.50M | 5473.40M | 3931.75M | 3862.53M |
| Stock based compensation | - | - | 20.20M | - | - |
| Other non cash items | 494.01M | -446.40M | -1623.80M | -226.24M | -372.95M |
| Free cash flow | 5686.90M | 5681.90M | 5785.50M | 4591.63M | 4596.34M |
Sector: Financial Services Industry: Insurance - Reinsurance
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
|---|---|---|---|---|---|---|---|
| HVRRF Hannover Rück SE |
- -% |
328.24 | 11.10 | 10.38 | 1.55 | 2.29 | 1.31 |
| MURGF Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München |
11.15 1.77% |
641.52 | 9.35 | 10.04 | 1.21 | 1.89 | 1.03 |
| MURGY Muenchener Rueckver Ges |
-0.02 0.16% |
12.73 | 9.46 | 10.13 | 1.21 | 1.90 | 1.03 |
| SSREY Swiss Re Ltd |
-0.53 1.13% |
46.51 | 10.42 | 9.05 | 1.21 | 2.01 | 1.21 |
| SSREF Swiss Re AG |
-1.42 0.76% |
184.52 | 10.26 | 8.97 | 1.19 | 1.99 | 1.21 |
Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services in Germany, the United Kingdom, France, Europe, the United States, Asia, Australia, Africa, and internationally. It operates through Property & Casualty Reinsurance; and Life & Health Reinsurance segments. The company provides property and casualty reinsurance solutions for agricultural, livestock, and bloodstock; aviation and space; natural catastrophe; credit, surety, and political risks; cyber; digital; marine and upstream energy; natural catastrophes; advanced and facultative business, insurance-linked securities and structured reinsurance; and parametric solutions. It also offers risk solutions in the areas of critical illness, disability, health, longevity, long term care, and mortality. In addition, the company offers group life, retirement, lifestyle, credit life, and Takaful reinsurance products. Further, the company provides various financial solutions, including new-business financing; monetization of embedded value; reserve and solvency relief; and reinsurance and solvency II businesses. The company was formerly known as Hannover Rückversicherung AG and changed its name to Hannover Rück SE in March 2013. Hannover Rück SE was founded in 1966 and is based in Hanover, Germany. Hannover Rück SE operates as a subsidiary of Talanx AG.
| Name | Title | Year Born |
|---|---|---|
| Mr. Jean-Jacques Henchoz | CEO & Chairman of the Exec. Board | 1964 |
| Mr. Clemens Jungsthofel | CFO & Member of Exec. Board | 1970 |
| Dr. Michael Pickel | Member of the Exec. Board | 1960 |
| Dr. Klaus Wilhelm Miller | Member of the Exec. Board | 1960 |
| Mr. Claude Jacques Chèvre | Member of the Exec. Board | 1967 |
| Mr. Sven Althoff | Member of the Exec. Board | 1969 |
| Ms. Silke Sehm | Member of Exec. Board | 1969 |
| Ms. Julia Hartmann | Sr. IR Mang.- Corp. Communications | NA |
| Mr. Karl Steinle | Head of Corp. Communications | NA |
| Michael Eberhardt | Managing Director of Hannover Re Australian Branch | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.